Michael LaBarre

Michael LaBarre

Chief Tech/Sci/R&D Officer at HALOZYME THERAPEUTICS, INC.

Net worth: 7 M $ as of 30/03/2024

60 year
Health Technology
Consumer Services
Finance

Profile

Michael J. LaBarre is Chief Technical Officer & Senior Vice President at Halozyme Therapeutics, Inc. In his past career Dr. LaBarre held the position of Director-Analytical & Protein Biochemistry at Biogen, Inc. and Director-Analytical & Formulation Sciences at IDEC Pharmaceuticals Corp. (a subsidiary of Biogen, Inc.) and Vice President-Product Development at Paramount BioSciences LLC. Dr. LaBarre received a doctorate from the University of Arizona and an undergraduate degree from Stony Brook University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
16/04/2024 168,176 ( 0.13% ) 7 M $ 30/03/2024

Michael LaBarre active positions

CompaniesPositionStart
HALOZYME THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 31/12/2019
All active positions of Michael LaBarre

Former positions of Michael LaBarre

CompaniesPositionEnd
BIOGEN INC. Corporate Officer/Principal 31/03/2006
Corporate Officer/Principal 30/11/2003
Corporate Officer/Principal -
See the detail of Michael LaBarre's experience

Training of Michael LaBarre

Stony Brook University Undergraduate Degree
University of Arizona Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael LaBarre's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BIOGEN INC.

Health Technology

HALOZYME THERAPEUTICS, INC.

Health Technology

Private companies2

Health Technology

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Michael LaBarre